BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 16088492)

  • 1. Pathogenesis of pulmonary vasculitis.
    Heeringa P; Schreiber A; Falk RJ; Jennette JC
    Semin Respir Crit Care Med; 2004 Oct; 25(5):465-74. PubMed ID: 16088492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of Disease: pathogenesis and treatment of ANCA-associated vasculitides.
    Kallenberg CG; Heeringa P; Stegeman CA
    Nat Clin Pract Rheumatol; 2006 Dec; 2(12):661-70. PubMed ID: 17133251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [ANCA-associated forms of vasculitis].
    Helmchen U; Kneissler U; Prall F
    Verh Dtsch Ges Pathol; 1996; 80():38-45. PubMed ID: 9065053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. -463 G/A myeloperoxidase promoter polymorphism is associated with clinical manifestations and the course of disease in MPO-ANCA-associated vasculitis.
    Reynolds WF; Stegeman CA; Tervaert JW
    Clin Immunol; 2002 May; 103(2):154-60. PubMed ID: 12027420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathogenesis of ANCA-associated vasculitides.
    Kallenberg CG
    Ann Rheum Dis; 2011 Mar; 70 Suppl 1():i59-63. PubMed ID: 21339221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathogenesis of PR3-ANCA associated vasculitis.
    Kallenberg CG
    J Autoimmun; 2008; 30(1-2):29-36. PubMed ID: 18162369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microscopic polyangiitis (microscopic polyarteritis).
    Jennette JC; Thomas DB; Falk RJ
    Semin Diagn Pathol; 2001 Feb; 18(1):3-13. PubMed ID: 11296991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thoughts about the classification of small vessel vasculitis.
    Falk RJ; Jennette JC
    J Nephrol; 2004; 17 Suppl 8():S3-9. PubMed ID: 15599883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ANCA-associated small-vessel vasculitis.
    Mansi IA; Opran A; Rosner F
    Am Fam Physician; 2002 Apr; 65(8):1615-20. PubMed ID: 11989638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathogenesis of vascular inflammation by anti-neutrophil cytoplasmic antibodies.
    Jennette JC; Xiao H; Falk RJ
    J Am Soc Nephrol; 2006 May; 17(5):1235-42. PubMed ID: 16624929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antineutrophil cytoplasmic antibodies.
    Bosch X; Guilabert A; Font J
    Lancet; 2006 Jul; 368(9533):404-18. PubMed ID: 16876669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of antineutrophil cytoplasmic antibodies and glomerular basement membrane antibodies in the diagnosis and monitoring of systemic vasculitides.
    Sinclair D; Stevens JM
    Ann Clin Biochem; 2007 Sep; 44(Pt 5):432-42. PubMed ID: 17761028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA genes in ANCA-associated vasculitides.
    Griffith ME; Pusey CD
    Exp Clin Immunogenet; 1997; 14(3):196-205. PubMed ID: 9493788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Causes and mechanisms of vasculitides].
    Lesavre P; Noël LH
    Rev Prat; 2000 Feb; 50(3):255-60. PubMed ID: 11923948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antineutrophil cytoplasmic autoantibody-associated alveolar capillaritis in patients presenting with pulmonary hemorrhage.
    Bosch X; López-Soto A; Mirapeix E; Font J; Ingelmo M; Urbano-Márquez A
    Arch Pathol Lab Med; 1994 May; 118(5):517-22. PubMed ID: 7910729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What do antineutrophil cytoplasmic antibodies (ANCA) tell us?
    Savige J; Pollock W; Trevisin M
    Best Pract Res Clin Rheumatol; 2005 Apr; 19(2):263-76. PubMed ID: 15857795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The environment, geoepidemiology and ANCA-associated vasculitides.
    Chen M; Kallenberg CG
    Autoimmun Rev; 2010 Mar; 9(5):A293-8. PubMed ID: 19892038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does infection play a role in the pathogenesis of pulmonary vasculitis?
    Capizzi SA; Specks U
    Semin Respir Infect; 2003 Mar; 18(1):17-22. PubMed ID: 12652450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone marrow-derived cells are sufficient and necessary targets to mediate glomerulonephritis and vasculitis induced by anti-myeloperoxidase antibodies.
    Schreiber A; Xiao H; Falk RJ; Jennette JC
    J Am Soc Nephrol; 2006 Dec; 17(12):3355-64. PubMed ID: 17108314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antineutrophil cytoplasmic autoantibody-associated small-vessel vasculitis.
    Kallenberg CG
    Curr Opin Rheumatol; 2007 Jan; 19(1):17-24. PubMed ID: 17143091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.